BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

264 related articles for article (PubMed ID: 25485510)

  • 1. Cyclin A/Cdk2 regulates Cdh1 and claspin during late S/G2 phase of the cell cycle.
    Oakes V; Wang W; Harrington B; Lee WJ; Beamish H; Chia KM; Pinder A; Goto H; Inagaki M; Pavey S; Gabrielli B
    Cell Cycle; 2014; 13(20):3302-11. PubMed ID: 25485510
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Degrading Claspin away with Cdh1 and Cyclin A.
    Burgess A
    Cell Cycle; 2015; 14(2):171. PubMed ID: 25584742
    [No Abstract]   [Full Text] [Related]  

  • 3. Dual regulation of the anaphase promoting complex in human cells by cyclin A-Cdk2 and cyclin A-Cdk1 complexes.
    Mitra J; Enders GH; Azizkhan-Clifford J; Lengel KL
    Cell Cycle; 2006 Mar; 5(6):661-6. PubMed ID: 16582612
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Deubiquitinase USP37 is activated by CDK2 to antagonize APC(CDH1) and promote S phase entry.
    Huang X; Summers MK; Pham V; Lill JR; Liu J; Lee G; Kirkpatrick DS; Jackson PK; Fang G; Dixit VM
    Mol Cell; 2011 May; 42(4):511-23. PubMed ID: 21596315
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A conserved cyclin-binding domain determines functional interplay between anaphase-promoting complex-Cdh1 and cyclin A-Cdk2 during cell cycle progression.
    Sørensen CS; Lukas C; Kramer ER; Peters JM; Bartek J; Lukas J
    Mol Cell Biol; 2001 Jun; 21(11):3692-703. PubMed ID: 11340163
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A subset of cancer cell lines is acutely sensitive to the Chk1 inhibitor MK-8776 as monotherapy due to CDK2 activation in S phase.
    Sakurikar N; Thompson R; Montano R; Eastman A
    Oncotarget; 2016 Jan; 7(2):1380-94. PubMed ID: 26595527
    [TBL] [Abstract][Full Text] [Related]  

  • 7. S and G2 phase roles for Cdk2 revealed by inducible expression of a dominant-negative mutant in human cells.
    Hu B; Mitra J; van den Heuvel S; Enders GH
    Mol Cell Biol; 2001 Apr; 21(8):2755-66. PubMed ID: 11283255
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Unmasking the redundancy between Cdk1 and Cdk2 at G2 phase in human cancer cell lines.
    L'Italien L; Tanudji M; Russell L; Schebye XM
    Cell Cycle; 2006 May; 5(9):984-93. PubMed ID: 16687918
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Uncovering the role of APC-Cdh1 in generating the dynamics of S-phase onset.
    Yuan X; Srividhya J; De Luca T; Lee JH; Pomerening JR
    Mol Biol Cell; 2014 Feb; 25(4):441-56. PubMed ID: 24356446
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cdc25-dependent activation of cyclin A/cdk2 is blocked in G2 phase arrested cells independently of ATM/ATR.
    Goldstone S; Pavey S; Forrest A; Sinnamon J; Gabrielli B
    Oncogene; 2001 Feb; 20(8):921-32. PubMed ID: 11314027
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Activation of CDC25A phosphatase is limited by CDK2/cyclin A-mediated feedback inhibition.
    Ditano JP; Sakurikar N; Eastman A
    Cell Cycle; 2021 Jul; 20(13):1308-1319. PubMed ID: 34156324
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cyclin A/cdk2 coordinates centrosomal and nuclear mitotic events.
    De Boer L; Oakes V; Beamish H; Giles N; Stevens F; Somodevilla-Torres M; Desouza C; Gabrielli B
    Oncogene; 2008 Jul; 27(31):4261-8. PubMed ID: 18372919
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nuclear translocation of Cyclin B1 marks the restriction point for terminal cell cycle exit in G2 phase.
    Müllers E; Silva Cascales H; Jaiswal H; Saurin AT; Lindqvist A
    Cell Cycle; 2014; 13(17):2733-43. PubMed ID: 25486360
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The regulation of Cdc20 proteolysis reveals a role for APC components Cdc23 and Cdc27 during S phase and early mitosis.
    Prinz S; Hwang ES; Visintin R; Amon A
    Curr Biol; 1998 Jun; 8(13):750-60. PubMed ID: 9651679
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cdh1 regulates cell cycle through modulating the claspin/Chk1 and the Rb/E2F1 pathways.
    Gao D; Inuzuka H; Korenjak M; Tseng A; Wu T; Wan L; Kirschner M; Dyson N; Wei W
    Mol Biol Cell; 2009 Jul; 20(14):3305-16. PubMed ID: 19477924
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Delta MEKK3:ER* activation induces a p38 alpha/beta 2-dependent cell cycle arrest at the G2 checkpoint.
    Garner AP; Weston CR; Todd DE; Balmanno K; Cook SJ
    Oncogene; 2002 Nov; 21(53):8089-104. PubMed ID: 12444545
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cdk5-mediated inhibition of APC/C-Cdh1 switches on the cyclin D1-Cdk4-pRb pathway causing aberrant S-phase entry of postmitotic neurons.
    Veas-Pérez de Tudela M; Maestre C; Delgado-Esteban M; Bolaños JP; Almeida A
    Sci Rep; 2015 Dec; 5():18180. PubMed ID: 26658992
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Cdc14B-Cdh1-Plk1 axis controls the G2 DNA-damage-response checkpoint.
    Bassermann F; Frescas D; Guardavaccaro D; Busino L; Peschiaroli A; Pagano M
    Cell; 2008 Jul; 134(2):256-67. PubMed ID: 18662541
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interphase APC/C-Cdc20 inhibition by cyclin A2-Cdk2 ensures efficient mitotic entry.
    Hein JB; Nilsson J
    Nat Commun; 2016 Mar; 7():10975. PubMed ID: 26960431
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of the E3 ubiquitin ligase RNF157 as a novel downstream effector linking PI3K and MAPK signaling pathways to the cell cycle.
    Dogan T; Gnad F; Chan J; Phu L; Young A; Chen MJ; Doll S; Stokes MP; Belvin M; Friedman LS; Kirkpatrick DS; Hoeflich KP; Hatzivassiliou G
    J Biol Chem; 2017 Sep; 292(35):14311-14324. PubMed ID: 28655764
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.